Sangcopan, Saidah .
HRN: 28-08-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/18/2025
12/19/2025
IV
500mg
BID X 2 Days
Sp CS
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes